Monday, August 10, 2026

Knowledge Files How We Source Search

#biotech financing

3 articles

FDA Priority Reviews and Cell Therapy Acquisitions Signal Biotech Sector Acceleration

Healthcare & Pharma Investment

FDA Priority Reviews and Cell Therapy Acquisitions Signal Biotech Sector Acceleration

Salvado•Apr 16, 2026

Artiva Biotherapeutics faces capital shortfall risk ahead of pivotal NK cell therapy trials

Corporate Finance

Artiva Biotherapeutics faces capital shortfall risk ahead of pivotal NK cell therapy trials

ViaNews Editorial Team (Finance)•Mar 7, 2026

Cardiff Oncology Burns Through $12M Per Quarter With 5 Quarters Of Cash Remaining

Corporate Finance

Cardiff Oncology Burns Through $12M Per Quarter With 5 Quarters Of Cash Remaining

ViaNews Editorial Team (Finance)•Mar 7, 2026